Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GNNSF

Genscript Biotech Corporation

USD

Set alert

Price alert · GNNSF

All alert types
4.50 USD 0.00 0.00%
As of Oct 29, 2026
4.38 Day range 4.38
1.30 52-week range 6.55
YTD
+171.08%
1 year
+109.30%
Open
4.38
Prev close
4.50
Mkt cap
10.26B
Vol
400
Avg vol
1.36K
EPS
-0.29
P/E
0.00
More statistics
Low
4.38
High
4.38

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GNNSF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

7.73 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -6.6×
FY 2016: 56.7×FY 2017: 181×FY 2018: 119×FY 2019: -46.1×FY 2020: -12.8×FY 2021: -25.3×FY 2022: -26.9×FY 2023: -53.9×FY 2024: 0.9×FY 2025: -6.6×
FY 2016 5y median -25.3× FY 2025
P/S 3.7×
FY 2016: 12.9×FY 2017: 30.9×FY 2018: 10.9×FY 2019: 16.3×FY 2020: 6.9×FY 2021: 18.1×FY 2022: 9.9×FY 2023: 6.1×FY 2024: 4.5×FY 2025: 3.7×
FY 2016 5y median 6.1× FY 2025
P/B 0.9×
FY 2016: 8.4×FY 2017: 21.6×FY 2018: 5.2×FY 2019: 11.7×FY 2020: 3.0×FY 2021: 8.8×FY 2022: 6.1×FY 2023: 3.7×FY 2024: 0.6×FY 2025: 0.9×
FY 2016 5y median 3.7× FY 2025
P/FCF 14.9×
FY 2016: 61.1×FY 2017: -445×FY 2018: 11.6×FY 2019: -30.1×FY 2020: -9.6×FY 2021: -33.7×FY 2022: -19.2×FY 2023: -11.6×FY 2024: -37.3×FY 2025: 14.9×
FY 2016 5y median -19.2× FY 2025
EV/EBITDA 12.2×
FY 2016: 35.5×FY 2017: 101×FY 2018: 56.8×FY 2019: -45.8×FY 2020: -12.3×FY 2021: -17.6×FY 2022: -15.6×FY 2023: -16.5×FY 2024: 38.4×FY 2025: 12.2×
FY 2016 5y median -15.6× FY 2025
EV/Sales 4.2×
FY 2016: 11.7×FY 2017: 30.1×FY 2018: 8.8×FY 2019: 15.5×FY 2020: 5.4×FY 2021: 16.1×FY 2022: 8.8×FY 2023: 4.9×FY 2024: 4.6×FY 2025: 4.2×
FY 2016 5y median 4.9× FY 2025
FCF Yield 6.7%
FY 2016: 1.6%FY 2017: -0.2%FY 2018: 8.6%FY 2019: -3.3%FY 2020: -10.4%FY 2021: -3.0%FY 2022: -5.2%FY 2023: -8.6%FY 2024: -2.7%FY 2025: 6.7%
FY 2016 5y median -3.0% FY 2025

Profitability

Gross Margin 57.7%
FY 2016: 66.4%FY 2017: 68.5%FY 2018: 68.6%FY 2019: 66.0%FY 2020: 65.5%FY 2021: 55.3%FY 2022: 48.6%FY 2023: 48.8%FY 2024: 45.8%FY 2025: 57.7%
FY 2016 5y median 48.8% FY 2025
Operating Margin 26.6%
FY 2016: 28.3%FY 2017: 24.5%FY 2018: 9.7%FY 2019: -41.0%FY 2020: -52.3%FY 2021: -72.1%FY 2022: -69.7%FY 2023: -49.5%FY 2024: 1.6%FY 2025: 26.6%
FY 2016 5y median -49.5% FY 2025
Net Margin -55.5%
FY 2016: 22.8%FY 2017: 17.1%FY 2018: 9.2%FY 2019: -35.5%FY 2020: -52.4%FY 2021: -70.2%FY 2022: -36.3%FY 2023: -11.4%FY 2024: 498.2%FY 2025: -55.5%
FY 2016 5y median -36.3% FY 2025
ROE -13.5%
FY 2016: 14.7%FY 2017: 12.0%FY 2018: 4.4%FY 2019: -25.3%FY 2020: -22.7%FY 2021: -34.3%FY 2022: -22.4%FY 2023: -6.9%FY 2024: 68.5%FY 2025: -13.5%
FY 2016 5y median -13.5% FY 2025
ROIC 5.5%
FY 2016: 15.3%FY 2017: 198.8%FY 2018: 3.2%FY 2019: -16.4%FY 2020: -17.5%FY 2021: -20.7%FY 2022: -21.1%FY 2023: -14.1%FY 2024: 0.2%FY 2025: 5.5%
FY 2016 5y median -14.1% FY 2025
ROA -11.0%
FY 2016: 11.6%FY 2017: 5.2%FY 2018: 2.3%FY 2019: -10.9%FY 2020: -14.2%FY 2021: -16.1%FY 2022: -8.9%FY 2023: -2.8%FY 2024: 56.1%FY 2025: -11.0%
FY 2016 5y median -8.9% FY 2025

Growth (YoY)

Revenue 61.6%
FY 2016: 32.3%FY 2017: 33.0%FY 2018: 51.3%FY 2019: 18.3%FY 2020: 43.0%FY 2021: 30.8%FY 2022: 22.4%FY 2023: 34.2%FY 2024: -29.2%FY 2025: 61.6%
FY 2016 FY 2025
Operating Income 2654.0%
FY 2016: 124.6%FY 2017: 15.2%FY 2018: -40.1%FY 2019: -599.7%FY 2020: -82.5%FY 2021: -80.1%FY 2022: -18.4%FY 2023: 4.6%FY 2024: 102.2%FY 2025: 2654.0%
FY 2016 FY 2025
EPS (diluted) -118.4%
FY 2016: 7.0%FY 2017: -1.3%FY 2018: -23.8%FY 2019: -554.8%FY 2020: -110.3%FY 2021: -63.6%FY 2022: 38.9%FY 2023: 58.8%FY 2024: 3102.2%FY 2025: -118.4%
FY 2016 FY 2025
Free Cash Flow 434.4%
FY 2016: 99.2%FY 2017: -143.6%FY 2018: 2135.3%FY 2019: -168.8%FY 2020: -87.8%FY 2021: 1.7%FY 2022: -18.1%FY 2023: -37.3%FY 2024: 83.7%FY 2025: 434.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 4.2×FY 2017: 1.5×FY 2018: 4.4×FY 2019: 2.5×FY 2020: 3.0×FY 2021: 3.5×FY 2022: 3.2×FY 2023: 4.8×FY 2024: 2.7×FY 2025: 1.5×
FY 2016 5y median 3.2× FY 2025
Quick Ratio 1.4×
FY 2016: 4.1×FY 2017: 1.4×FY 2018: 4.3×FY 2019: 2.4×FY 2020: 2.9×FY 2021: 3.4×FY 2022: 3.1×FY 2023: 4.6×FY 2024: 2.6×FY 2025: 1.4×
FY 2016 5y median 3.1× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 1.3×
FY 2016: -3.6×FY 2017: -2.7×FY 2018: -13.6×FY 2019: 2.5×FY 2020: 3.3×FY 2021: 2.2×FY 2022: 1.9×FY 2023: 4.1×FY 2024: 0.5×FY 2025: 1.3×
FY 2016 5y median 1.9× FY 2025
Interest Coverage 14.8×
FY 2016: 3252×FY 2017: 0.0×FY 2018: 431×FY 2019: -144×FY 2020: -37.6×FY 2021: -155×FY 2022: -32.9×FY 2023: -15.1×FY 2024: 1.2×FY 2025: 14.8×
FY 2016 5y median -15.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 10.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31